Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Liabilities (2016 - 2019)

Historic Total Liabilities for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $13.8 million.

  • Soleno Therapeutics' Total Liabilities fell 1677.69% to $13.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $13.8 million, marking a year-over-year decrease of 1677.69%. This contributed to the annual value of $12.7 million for FY2018, which is 436.71% up from last year.
  • Per Soleno Therapeutics' latest filing, its Total Liabilities stood at $13.8 million for Q3 2019, which was down 1677.69% from $20.3 million recorded in Q2 2019.
  • Soleno Therapeutics' 5-year Total Liabilities high stood at $21.4 million for Q1 2015, and its period low was $2.1 million during Q4 2016.
  • In the last 5 years, Soleno Therapeutics' Total Liabilities had a median value of $12.2 million in 2017 and averaged $10.2 million.
  • As far as peak fluctuations go, Soleno Therapeutics' Total Liabilities tumbled by 8335.99% in 2016, and later soared by 47309.75% in 2017.
  • Over the past 5 years, Soleno Therapeutics' Total Liabilities (Quarter) stood at $5.0 million in 2015, then crashed by 57.21% to $2.1 million in 2016, then surged by 473.1% to $12.2 million in 2017, then rose by 4.37% to $12.7 million in 2018, then rose by 8.65% to $13.8 million in 2019.
  • Its last three reported values are $13.8 million in Q3 2019, $20.3 million for Q2 2019, and $15.2 million during Q1 2019.